Ellen R. Cooper, MD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Ellen Cooper is Professor of Pediatrics at Chobanian and Avedisian School of Medicine, and is in the Division of Pediatric Infectious Diseases at Boston Medical Center. She founded and still directs the Pediatric HIV Program which now also includes an Adolescent HIV Initiative. In addition she leads the Transition Program for older adolescents who are transitioning to adult care.

She has published widely on the subject of Pediatric HIV treatment and care. She was a principal investigator of a large US based study designed to answer questions surrounding the perinatal transmission of HIV, and this continues to be one of her special interests. She was one of the original members of the HIV Consensus Committee, whose purpose was to establish guidelines for the diagnosis and treatment of HIV infected infants in the US, and her expertise led her to focus also on treatment and care in a number of high burden and low resource countries. She has worked in sites in Uganda, Cameroon, South Africa, Zambia, and in Ethiopia.

She was a participant, trainer and advisor to curriculum development and implementation for the MTCT-Plus Programs in Africa, and served as a technical advisor for ICAP, Columbia in their efforts to establish a Center of Excellence for the care of HIV infected children in Zambia. She continues to be an active participant in the NIH sponsored IMPAACT Network.

Publications

  • Published 1/20/2025

    Rozen Eisenberg I, Campbell JI, Clarke D, Cooper ER, Pelton SI, Vuppula SS. Practice Variability in Uptake and Implementation of New U.S. DHHS Guidelines for Feeding of HIV-Exposed Infants. J Pediatric Infect Dis Soc. 2025 Jan 20; 14(1). PMID: 39726301.

    Read at: PubMed

  • Published 2/1/2023

    Melvin AJ, Yee KL, Gray KP, Yedla M, Wan H, Tobin NH, Teppler H, Campbell H, McCarthy K, Scheckter R, Aurpibul L, Ounchanum P, Rungmaitree S, Cassim H, McFarland E, Flynn P, Cooper E, Krotje C, Townley E, Moye J, Best BM. Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014. J Acquir Immune Defic Syndr. 2023 Feb 01; 92(2):153-161. PMID: 36215957.

    Read at: PubMed

  • Published 11/21/2022

    Fee C, Fuller J, Guss CE, Woods ER, Cooper ER, Bhaumik U, Graham D, Burchett SK, Dumont O, Martey EB, Narvaez M, Haberer JE, Swendeman D, Mulvaney SA, Kumar VS, Jackson JL, Ho YX. A Digital Platform to Support HIV Case Management for Youth and Young Adults: Mixed Methods Feasibility Study. JMIR Form Res. 2022 Nov 21; 6(11):e39357. PMID: 36409541.

    Read at: PubMed

  • Published 4/14/2021

    Sabharwal V, Bartolome R, Hassan SA, Levesque BM, Camelo IY, Wachman EM, Figueira M, Yarrington CD, Cooper ER, Barnett ED, Parker MG. Mother-Infant Dyads with COVID-19 at an Urban, Safety-Net Hospital: Clinical Manifestations and Birth Outcomes. Am J Perinatol. 2021 06; 38(7):741-746. PMID: 33853145.

    Read at: PubMed

  • Published 3/26/2021

    Epstein RL, Penwill N, Clarke DF, Hamilton S, Horbowicz K, Dorfman D, Moses JM, Cooper ER. "Meds-in-Hand" Intervention to Reduce Critical Process Delays in Pediatric Human Immunodeficiency Virus Post-Exposure Prophylaxis. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):196-200. PMID: 32347312.

    Read at: PubMed

View All 146 Publications:   View Full Profile in BUMC

Websites

Education

  • University of Cincinnati College of Medicine, MD
  • Johns Hopkins University, MA
  • Wellesley College, BS

View all profiles